PING-ING LEEHuang Y.-C.Hwang K.-P.Liu C.-C.Chiu C.-H.Chen P.-Y.CHUN-YI LUChen C.-J.LUAN-YIN CHANGChiu N.-C.Chi H.Lin H.-C.Wu K.-G.Ho Y.-H.Sun W.Lin T.-Y.2020-12-152020-12-1520201875-9572https://www.scopus.com/inward/record.uri?eid=2-s2.0-85076849678&doi=10.1016%2fj.pedneo.2019.11.009&partnerID=40&md5=50f9b4b77b18f26f2dbaa1e53449e21bhttps://scholars.lib.ntu.edu.tw/handle/123456789/525484Japanese encephalitis (JE) is a mosquito-borne viral infection which is prevalent in Taiwan. The virus circulates in an enzootic cycle in pigs which serve as amplifying hosts. Outbreaks typically occur during summer. A universal vaccination program using 4-shot mouse brain-derived inactivated vaccine has successfully controlled JE epidemics in Taiwan since 1968. More than 90% of JE cases in recent years were older than 20 years in Taiwan. Because of several drawbacks, mouse brain-derived vaccine has been replaced by newer generation JE vaccines, including inactivated Vero cell-derived vaccine and live chimeric vaccine. The present article describes the recommendations in Taiwan for the use of new JE vaccines and the schedules for shifting between different JE vaccines. ? 2019[SDGs]SDG3inactivated vaccine; Japanese encephalitis vaccine; live vaccine; inactivated vaccine; Japanese encephalitis vaccine; human; Japanese encephalitis; Japanese encephalitis virus; nonhuman; practice guideline; Review; Taiwan; vaccination; Vero cell line; virus transmission; immunology; Japanese encephalitis; Encephalitis, Japanese; Humans; Japanese Encephalitis Vaccines; Taiwan; Vaccination; Vaccines, Inactivatedreview10.1016/j.pedneo.2019.11.009318705592-s2.0-85076849678